tradingkey.logo

Co-Diagnostics Inc

CODX
0.235USD
-0.006-2.41%
收盘 12/26, 16:00美东报价延迟15分钟
11.31M总市值
亏损市盈率 TTM

Co-Diagnostics Inc

0.235
-0.006-2.41%

关于 Co-Diagnostics Inc 公司

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Co-Diagnostics Inc简介

公司代码CODX
公司名称Co-Diagnostics Inc
上市日期Jul 12, 2017
CEOEgan (Dwight H)
员工数量132
证券类型Ordinary Share
年结日Jul 12
公司地址2401 S. Foothill Dr. Suite D
城市SALT LAKE CITY
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编84109
电话18014381036
网址https://codiagnostics.com/
公司代码CODX
上市日期Jul 12, 2017
CEOEgan (Dwight H)

Co-Diagnostics Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Richard Abbott
Mr. Richard Abbott
President
President
618.65K
+2.30%
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
329.17K
+21.17%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
326.67K
+21.36%
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Richard Abbott
Mr. Richard Abbott
President
President
618.65K
+2.30%
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
329.17K
+21.17%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
326.67K
+21.36%
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
162.91K
0.00%
Rest of the world
0.00
0.00%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 12月4日 周四
更新时间: 12月4日 周四
持股股东
股东类型
持股股东
持股股东
占比
Ayrton Capital LLC
6.14%
Orca Capital GmbH
3.10%
The Vanguard Group, Inc.
2.80%
Private Advisory Group LLC
1.94%
Renaissance Technologies LLC
1.42%
其他
84.60%
持股股东
持股股东
占比
Ayrton Capital LLC
6.14%
Orca Capital GmbH
3.10%
The Vanguard Group, Inc.
2.80%
Private Advisory Group LLC
1.94%
Renaissance Technologies LLC
1.42%
其他
84.60%
股东类型
持股股东
占比
Investment Advisor
9.44%
Hedge Fund
7.58%
Individual Investor
5.87%
Investment Advisor/Hedge Fund
1.00%
Research Firm
0.44%
Bank and Trust
0.05%
其他
75.62%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
80
11.14M
13.43%
-308.03K
2025Q3
83
11.45M
12.86%
+6.26M
2025Q2
88
5.18M
18.12%
-695.54K
2025Q1
96
5.88M
20.77%
-1.09M
2024Q4
104
5.75M
18.48%
+1.31M
2024Q3
108
4.45M
20.26%
-229.17K
2024Q2
125
4.65M
21.94%
+232.83K
2024Q1
134
4.41M
23.86%
-3.05M
2023Q4
144
4.75M
24.82%
-54.54K
2023Q3
160
4.81M
26.97%
+93.65K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Orca Capital GmbH
2.19M
4.56%
+2.19M
--
Sep 18, 2025
The Vanguard Group, Inc.
1.73M
3.6%
-44.94K
-2.53%
Jun 30, 2025
Private Advisory Group LLC
1.18M
2.45%
--
--
Jun 30, 2025
Renaissance Technologies LLC
561.02K
1.17%
+10.70K
+1.94%
Jun 30, 2025
Egan (Dwight H.)
748.18K
1.55%
+111.64K
+17.54%
May 23, 2025
Abbott (Richard David)
631.47K
1.31%
+12.82K
+2.07%
May 23, 2025
Brown (Brian Lee)
599.30K
1.24%
+86.00K
+16.76%
May 23, 2025
BlackRock Institutional Trust Company, N.A.
427.44K
0.89%
-69.29K
-13.95%
Jun 30, 2025
Serbin (Richard S)
262.50K
0.55%
+48.33K
+22.57%
May 23, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
占比0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Co-Diagnostics Inc的前五大股东是谁?

Co-Diagnostics Inc 的前五大股东如下:
Orca Capital GmbH持有股份:2.19M,占总股份比例:4.56%。
The Vanguard Group, Inc.持有股份:1.73M,占总股份比例:3.60%。
Private Advisory Group LLC持有股份:1.18M,占总股份比例:2.45%。
Renaissance Technologies LLC持有股份:561.02K,占总股份比例:1.17%。
Egan (Dwight H.)持有股份:748.18K,占总股份比例:1.55%。

Co-Diagnostics Inc的前三大股东类型是什么?

Co-Diagnostics Inc 的前三大股东类型分别是:
Ayrton Capital LLC
Orca Capital GmbH
The Vanguard Group, Inc.

有多少机构持有Co-Diagnostics Inc(CODX)的股份?

截至2025Q4,共有80家机构持有Co-Diagnostics Inc的股份,合计持有的股份价值约为11.14M,占公司总股份的13.43%。与2025Q3相比,机构持股有所增加,增幅为0.57%。

哪个业务部门对Co-Diagnostics Inc的收入贡献最大?

在FY2025Q2,--业务部门对Co-Diagnostics Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI